Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herrmann

Showing results (901-910 of 16,764) with videos related to

Pageof 1,677
Sort By:
Therapeutische Umschau. Revue Therapeutique|November 1, 1996
[Possibilities and prospects in gene therapy in cancer patients]C F Rochlitz, R Herrmann
FEBS Letters|October 18, 1993
Enhancement of Ca2+ release channel activity by phosphorylation of the skeletal muscle ryanodine receptorA Herrmann-Frank, M Varsányi
Intervirology|January 1, 1993
Autoimmune diseases in humans, e.g. autoimmune rheumatic diseasesJ R Kalden, M Herrmann
Pharmacopsychiatry|July 1, 1996
Effect and efficacy--on the function of models in controlled phase III trials and the need for prospective pharmacoepidemiological studiesG Winterer, W M Herrmann
Praxis|November 21, 1995
[Adjuvant treatment of colonic carcinoma]C F Rochlitz, R Herrmann
Pharmacopsychiatria|September 1, 1983
An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitationsW M Herrmann, U Irrgang
Acta Neurochirurgica|January 1, 1980
Spinal elastance measurement in patients with spondylogenic narrowing of the spinal canalH D Herrmann, H Jaksche
Schweizerische Medizinische Wochenschrift|December 19, 1981
[The clinical significance of compliance]J M Herrmann, E Gaus
Postgraduate Medicine|January 1, 1980
Genetic counselingJ Herrmann, J M Opitz
Hearing Research|July 19, 2020
A model of listening engagement (MoLE)Björn Herrmann, Ingrid S Johnsrude
Pageof 1,677

Showing results (901-910 of 16,764) with videos related to

Sort By:
Pageof 1,677
Therapeutische Umschau. Revue Therapeutique|November 1, 1996
[Possibilities and prospects in gene therapy in cancer patients]C F Rochlitz, R Herrmann
FEBS Letters|October 18, 1993
Enhancement of Ca2+ release channel activity by phosphorylation of the skeletal muscle ryanodine receptorA Herrmann-Frank, M Varsányi
Intervirology|January 1, 1993
Autoimmune diseases in humans, e.g. autoimmune rheumatic diseasesJ R Kalden, M Herrmann
Pharmacopsychiatry|July 1, 1996
Effect and efficacy--on the function of models in controlled phase III trials and the need for prospective pharmacoepidemiological studiesG Winterer, W M Herrmann
Praxis|November 21, 1995
[Adjuvant treatment of colonic carcinoma]C F Rochlitz, R Herrmann
Pharmacopsychiatria|September 1, 1983
An absolute must in clinico-pharmacological research: pharmaco-electroencephalography, its possibilities and limitationsW M Herrmann, U Irrgang
Acta Neurochirurgica|January 1, 1980
Spinal elastance measurement in patients with spondylogenic narrowing of the spinal canalH D Herrmann, H Jaksche
Schweizerische Medizinische Wochenschrift|December 19, 1981
[The clinical significance of compliance]J M Herrmann, E Gaus
Postgraduate Medicine|January 1, 1980
Genetic counselingJ Herrmann, J M Opitz
Hearing Research|July 19, 2020
A model of listening engagement (MoLE)Björn Herrmann, Ingrid S Johnsrude
Pageof 1,677